Trial NCT03630809

View at ClinicalTrials.gov 
Org. Study IDs: MCC-19650

Last trial update was posted on 2022-04-25

MeSH Interventions

Vaccines

MeSH Conditions

Breast Neoplasms Breast Neoplasms, Male

Other Conditions

Breast Cancer Breast Cancer Female Breast Cancer, Male HER-2 Gene Amplification HER-2 Protein Overexpression HER2 Positive Breast Carcinoma HER2-positive Breast Cancer

Stopping Reasons

Quality of the data originating from prior versions of the protocol has been affected by protocol deviations triggered by the COVID-19 pandemics

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID